Open AccessUtility of FDG-PET-CT scanning in assessing the extent of disease activity and response to treatment in sarcoidosis
Author(s) -
Randeep Guleria,
Amudhan Jyothidasan,
Karan Madan,
Anant Mohan,
Rakesh Kumar,
Ashu Seith Bhalla,
Arun Malhotra
Publication year - 2014
Publication title -
lung india
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 25
eISSN - 0974-598X
pISSN - 0970-2113
DOI - 10.4103/0970-2113.142092
Subject(s) - medicine , sarcoidosis , positron emission tomography , radiology , radiological weapon , pet ct , metabolic activity , nuclear medicine , disease , physiology
Radionuclide imaging modalities have increasingly been evaluated in the assessment of organ involvement in sarcoidosis. Fluoro-deoxyglucose positron emission tomography-computed tomography (FDG-PET-CT) scanning has received increasing attention in the recent years. The aim of our study was to evaluate the utility of FDG-PET-CT in determining the extent of organ involvement and disease activity in patients of sarcoidosis and to assess its utility in the evaluation of response to therapy. The secondary objective was to compare the agreement between clinical, radiological (HRCT) and metabolic indices (FDG-PET-CT) of disease activity.